NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market on Wednesday that its first quarter revenues rose 28 percent on the strength of its reproductive health diagnostics business.

For the quarter ended March 31, the molecular diagnostics developer reported revenues of $3.0 million, up from $2.3 million a year ago.

Diagnostics services revenues made up $2.9 million of the total, a 26 percent increase over the $2.3 million the company reported in Q1 2015. Revenues from royalties totaled $42,000 for the quarter, flat with the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.